Patent ID: 8680088
Filing Date: 2014-03-25
Classification: A61K,A61M,A61P

Abstract:
1. A method of treating a central sensitization disorder selected from the group consisting of fibromyalgia, irritable bowel syndrome, a chronic arthropathy, post herpetic neuralgia, trigeminal neuralgia, an autonomic neuropathy, a metabolic neuropathy, a post-surgical pain syndrome, post traumatic stress disorder (PTSD) pain syndrome, Major Depressive Disorder, vulvodynia syndrome, a spinal nerve compression syndrome, a migraine, and osteoarthritis, in a human, comprising: providing a delivery device, wherein the delivery device comprises HCG; and administering HCG to the human with the device at a daily dosage of HCG between 120 IU/day and 170 IU/day, inclusive, wherein at least one symptom associated with the central sensitization disorder is ameliorated following administration.